This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Oxycodone Market

Market Insights on Oxycodone covering sales outlook, demand forecast & up-to-date key trends

Oxycodone Market by Oxycodone Type (Long-acting oxycodone, Short-acting oxycodone), Application (Pain Management, De-addiction), Distribution Channel (Hospital Pharmacies, Retail Pharmacies) & Region - Forecast to 2021-2031

Oxycodone Market Snapshot

As per recently updated report by Future Market Insights, oxycodone sales will rise consistently at 4.8% CAGR between 2021 and 2031. Driven by surging demand for effective pain management solutions, the oxycodone market valuation is forecast to surpass US$ 4.6 Bn in 2021.

Growth predictions remain positive for North America due to increasing healthcare expenditure in the U.S. and Canada. Spurred by this, the North America oxycodone worth is projected to reach US$ 1.85 Bn in 2021.

Customize this Report

Let us know your requirement to get
100% FREE customization

Key Points Covered in Oxycodone Market Study

  • Market estimates and forecast 2021 – 2031
  • Key drivers and restrains impacting market growth
  • Segment-wise, Country-wise, and Region-wise Analysis
  • Competitive Mapping and Benchmarking
  • Brand share and Market Share Analysis
  • Key Product Innovations and Regulatory Climate
  • COVID-19 Impact On Oxycodone Market
  • Recommendation on Key Winning Strategies

2016 – 2020 Oxycodone Market Outlook In Comparison to 2021 – 2031 Forecast

The demand for pain management medication is rising consistent, which will create prospects for expansion of the oxycodone market. According to FMI, the market exhibited a CAGR of 5% between 2016 and 2020. 

The growth trend will continue in response to increasing healthcare spending registered globally. Considering this, the rising cases of chronic ailments such as rheumatoid arthritis will rev up growth opportunities for the market.

Oxycodone is known as a type of opioid consumed to monitor pain management, anaesthesia, and de-addiction. There are usually two types of oxycodone form based on their component, one being long-activity component and other short-activity component.

They are also known to provide relief after operation, surgeries, and other medical conditions, thus boosting the demand for oxycodone in the global market.

Rising number of chronic diseases such as fibromyalgia, arthritis, lower back pain, and others is accelerating the demand for pain relieving opioids.

The demand for oxycodone is expected to rise globally as it is prescribed as an analgesic for post-operative pain, HIV, and cancer medication. According to the Centre for Disease Control and Prevention, 239 million surgeries were conducted in 2013.

Around 65% of the patients witnessed moderate to severe post-operative pain therefore, bolstering the adoption of oxycodone market as an opioid pain management drug.

The global oxycodone market is expected to face certain restrains as there has been an increased opioid abuse and mortality. In 2017, opioid has led to 66% of drug overdose deaths in the U.S alone. However, in the coming years, the market will gain from government support and development of new drug that do not cause addiction.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

How will Increasing Prevalence of Chronic Diseases Affect Oxycodone Market?

Rising number of chronic disorders has been shaping the growth of the oxycodone market. It is often prescribed for pain management post surgeries. One of the key driving factors is the rising prevalence of Parkinson’s syndrome.

According to BlueCross BlueShieldm prevalence of Parkinson’s disease is gradually rising in young adults. Also, as per Parkinson’s Foundation, in the U.S., nearly 1 million people are living with the condition. 

Parkinson’s patients with severe pain are sometimes prescribed long-acting oxycodone treatment. They showed relevant clinical improvements relative to placebo.

Rheumatic and cancer patients also benefit from oxycodone as it helps in improving pain management. Oxycodone is also primarily used as pain reliever after operations and surgeries thus, gaining momentum from these developments.

Considering this, the rising application of oxycodone in pain management will create scope for expansion of the market in the near future.

Restrains Give Way to New Development in the Global Oxycodone Market

Opioids aid majorly in relieving pain therefore, they are classified as addictive in nature. Although they provide cost-effective solutions to patients suffering from pain caused due to various ailments, they are addictive in nature and therefore can be abused.

Opioid consumption has major side effects such as euphoria, slowed breathing, nausea, constipation, drowsiness, and confusion. Research and development activities along with government reimbursement to develop oxycodone drugs to prevent addiction associated with opioids are likely to open new gateways for market growth during the forecast period.

Increased new drug applications and products in the pipeline in pharmaceutical companies will drive the market for oxycodone.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Country-wise Analysis

Will U.S. Remain a Key Oxycodone Market?

The U.S. is expected to lead the global market as this country has substantial purchasing power owing to its large economy. According to National Health Accounts by Centers for Medicare & Medicaid Services (CMS), healthcare spending in the country grew by 4.6% in 2019.

With expenditure on healthcare forecast to rise further, the demand for oxycodone will continue rising in the U.S. The market also will gain from rising cases of chronic ailments in the country.

This country also showcases the presence of key players such as Purdue Pharma, Pfizer Inc., Janssen Pharmaceuticals Inc., Endo Pharmaceuticals, and others. Therefore, the oxycodone market in the U.S. is likely show promising growth in the coming years.

How Will Oxycodone Market Growth Unfold in GCC Countries?

Gulf countries dominate the Middle East and Africa oxycodone market due to their substantial wealth and public healthcare expenditure.

According to 2018 GCC Healthcare Industry Report compiled by Alpen Capital, healthcare expenditure in the region is expected to reach over US$ 104 Bn by 2022.

With demand for advanced healthcare consistently rising, GCC countries will offer impressive growth opportunities for the oxycodone market.

What are the Factors Driving Oxycodone Demand in the U.K.?

According to the Office of National Statistics, U.K., in 2018, the healthcare expenditure in the U.K. accounted for 10% which was £214.4 billion. Government financed healthcare expenditure grew by 2.0%.

Increasing healthcare expenditure in the country is related to the rising cases of chronic ailments. Thanks to better access to information, not only are people better aware about various medical conditions, they are willing to spend on advanced healthcare.

This is expected to reflect positively on the U.K. market, presenting conducive environment for the growth of oxycodone sales.

What are the Factors Driving Oxycodone Market Growth in India?

According to Indian Council of Medical Research (ICMR) and India’s National Centre for Disease Informatics and Research, the number of cancer cases in male alone is around 6,79,421 and will likely reach 7,63,575 by 2025.

Oxycodone Market Download Report Brochure

The rise of cancer cases will fuel the demand for pain management solutions. This will bode well for the oxycodone market growth in India.

Besides this, expansion of the healthcare sector to support soaring healthcare needs of its citizens, will create opportunities for growth in India.

Category-wise Insights

Why is long-acting oxycodone gaining popularity?

Long acting oxycodone is expected to register higher sales compared to short acing oxycodone as it has reduced frequency of dosing and provide extended analgesia over longer intervals.

It is known to provide extended treatment for patients with persistent pain levels and for those on whom non-opioid treatment has failed to provide tolerable analgesia.

Its demand is expected to rise as it provides consistent and prolonged plasma dug levels with lesser peak and trough fluctuations. Additionally, long acting oxycodone provide improved dosing schedule and reduces clock-watching between doses.

Why hospital pharmacies will exhibit more demand?

Hospital pharmacies are expected to grow substantially during the forecast period owing to large scale development of specialty hospitals and increased purchasing powers. Increasing penetration of healthcare insurance and consolidation of healthcare giants are expected to drive the hospital pharmacies further.

Competitive Landscape

The global oxycodone market is highly fragmented as there are numerous notable players operating in the market. Key players are actively investing in research development activities to expand their product portfolio along with adopting strategies such as mergers, joint ventures, and acquisition to stay ahead in the competition.

For instance:

  • Teva Pharmaceutical Industries Ltd. got FDA approval for VANTRELATM ER extended-release tablets that were formulated with Teva’s proprietary abuse deterrence technology for managing daily severe pain. The product’s approval was supported by a clinical program to evaluate efficacy, safety, and abuse potential of VANTRELA ER.
  • Purdue Pharma signed an agreement with U.S. Department of Justice to deliver more than $10 billion in value opioid crisis to communities and claimants.
  • Mylan and Pfizer collaborated under combination of Mylan and Upjohn to form Viatris. The company is expected to flourish into a sustainable healthcare journey by expanding medicine access and meeting patient needs.

Leading oxycodone manufacturers as profiled by FMI include:

  • Teva Pharmaceutical Industries Ltd.
  • Purdue Pharma L.P
  • Daiichi Sankyo
  • Acorda Therapeutics
  • Teikoku Pharma USA, Inc.
  • Mylan N.V
  • Endo Pharmaceuticals Inc.
  • Janssen Pharmaceuticals, Inc.

This list is indicative - full details about prominent oxycodone manufacturers is available upon request

Oxycodone Market – Report Scope

Attribute

Details

Forecast Period

2021 – 2031

Historical Data Available for

2016 – 2020

Market Analysis

US$ Mn for Value & Units for Volume

Key Regions Covered

North America, Latin America, Europe, Asia Pacific and  Middle East & Africa

Key Countries Covered

US, Canada, Brazil, Mexico, Argentina, Germany, UK, Spain, France, Italy, Russia, India, China, Japan, South Korea, the Philippines, Malaysia, Thailand, Australia, New Zealand, GCC, Turkey, Israel, Turkey, Iran and South Africa

Key Segments Covered

Product type, Application segment, Distribution channel and Region

Key Companies Profiled

  • Teva Pharmaceutical Industries Ltd.
  • Purdue Pharma L.P
  • Daiichi Sankyo
  • Acorda Therapeutics
  • Teikoku Pharma USA, Inc.
  • Mylan N.V
  • Endo Pharmaceuticals Inc.
  • Janssen Pharmaceuticals, Inc.

Report Coverage

Market Overview, Market Background, Market Forecast, Segmental Analysis, Regional Profiling and Competition Analysis

Customization & Pricing

Available upon Request

Key Segments Covered in Oxycodone Market Study

By Oxycodone Type:

  • Long-acting oxycodone
  • Short-acting oxycodone

By Application:

  • Pain Management
  • De-addiction

By Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies

By Region

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa

Frequently Asked Questions

Driven by increasing demand for pain management solutions, the oxycodone market size is forecast to reach US$ 4.6 Bn in 2021

Between 2016 and 2020, the oxycodone sales surged at a 5% CAGR. The market’s valuation stood at US$ 3.67 Bn in 2020.

There is increase focus on new drug development in the market. Companies are currently focusing on discovery of abuse-deterrent drugs. Besides this, launch of extended-release medications are expected to bode well for the oxycodone market.

Rising prevalence of chronic ailments and the resultant demand for effective pain management solutions will remain the chief growth driver. The market also will gain from rising spending on advanced healthcare.

Demand registered in North America will continue rising, backed increasing sales in the U.S. and Canada, the North America market will reach a valuation of US$ 1.85 Bn in 2021.

Purdue Pharma LP, Pfizer Inc., Janssen Pharmaceuticals, Inc., Teva Pharmaceuticals, Endo International Plc, West-Ward Pharmaceuticals (Hikma’s US subsidiary), Mallinckrodt Pharmaceuticals Plc, Mylan N.V, Impax Laboratories, Inc, and Indivior Plc. Are the top ten companies in the market.

Top players account for nearly 35% to 40% of the oxycodone market

Oxycodone sales will increase at 5% CAGR in Europe, backed by rising demand in the U.K., Germany, and other countries.

Leading countries driving demand in the oxycodone market are the U.S., France, the U.K., Japan, and Australia.

Japan and South Korea held 3.2% and 0.5% share, respectively in the overall oxycodone market in 2020.

Table of Content

1. Executive Summary

    1.1. Market Overview

    1.2. Market Analysis

    1.3. FMI Analysis and Recommendations

    1.4. Wheel of Fortune

2. Market Introduction

    2.1. Market Taxonomy

    2.2. Market Definition

    2.3. Company Description and Oxycodone Market Research Coverage

3. Regulatory Scenario Global Economic Outlook

    3.1. Oxycodone Market Outlook

4. Oxycodone Market Opportunity Analysis

    4.1. Macro-Economic Factors

    4.2. Opportunity Analysis

5. Market Background

    5.1. List of Growth Hacking Manufacturers

    5.2. Market Dynamics

        5.2.1. Drivers

        5.2.2. Restraints

        5.2.3. Trends

        5.2.4. Opportunity

    5.3. Regulatory Scenario

6. Key Inclusions

    6.1. Synthetic Opioids Per Capita Consumption

    6.2. Regulatory Agencies

    6.3. Synthetic Opioids, State wise Analysis

    6.4. Healthcare Burden

    6.5. Region Wise Opioid Painkillers Demand Scenario

    6.6. Global Key Competition Mapping

7. North America Oxycodone Market Analysis 2016 – 2020 and Forecast 2021 – 2031

    7.1. Introduction

    7.2. Historical Market Size (US$ Mn) Analysis By Country, 2016 – 2020

        7.2.1. U.S.

        7.2.2. Canada

    7.3. Market Size (US$ Mn) Forecast By Country, 2021 – 2031

    7.4. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2016 – 2020

        7.4.1. Long Acting Oxycodone

        7.4.2. Short Acting Oxycodone

    7.5. Market Size (US$ Mn) Forecast By Product Type, 2021 – 2031

    7.6. Historical Market Size (US$ Mn) Trend Analysis By Application, 2016 – 2020

        7.6.1. Pain Management

        7.6.2. De-Addiction

    7.7. Market Size (US$ Mn) Forecast By Application, 2021 – 2031

    7.8. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2016 – 2020

        7.8.1. Retail Pharmacies

        7.8.2. Hospitals Pharmacies

    7.9. Market Size (US$ Mn) Forecast By Distribution Channel, 2021 – 2031

    7.10. Market Attractiveness Analysis

        7.10.1. By Country

        7.10.2. By Product Type

        7.10.3. By Application

        7.10.4. By Distribution Channel

    7.11. Key Mergers & Acquisitions

8. Latin America Oxycodone Market Analysis 2016 – 2020 and Forecast 2021 – 2031

    8.1. Introduction

    8.2. Historical Market Size (US$ Mn) Analysis By Country, 2016 – 2020

        8.2.1. Brazil

        8.2.2. Mexico

        8.2.3. Rest of Latin America

    8.3. Market Size (US$ Mn) Forecast By Country, 2021 – 2031

    8.4. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2016 – 2020

        8.4.1. Long Acting Oxycodone

        8.4.2. Short Acting Oxycodone

    8.5. Market Size (US$ Mn) Forecast By Product Type, 2021 – 2031

    8.6. Historical Market Size (US$ Mn) Trend Analysis By Application, 2016 – 2020

        8.6.1. Pain Management

        8.6.2. De-Addiction

    8.7. Market Size (US$ Mn) Forecast By Application, 2021 – 2031

    8.8. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2016 – 2020

        8.8.1. Retail Pharmacies

        8.8.2. Hospitals Pharmacies

    8.9. Market Size (US$ Mn) Forecast By Distribution Channel, 2021 – 2031

    8.10. Market Attractiveness Analysis

        8.10.1. By Country

        8.10.2. By Product Type

        8.10.3. By Application

        8.10.4. By Distribution Channel

    8.11. Key Mergers & Acquisitions

9. Europe Oxycodone Market Analysis 2016 – 2020 and Forecast 2021 – 2031

    9.1. Introduction

    9.2. Historical Market Size (US$ Mn) Analysis By Country, 2016 – 2020

        9.2.1. EU-4

        9.2.2. U.K.

        9.2.3. Russia

        9.2.4. Rest of Europe

    9.3. Market Size (US$ Mn) Forecast By Country, 2021 – 2031

    9.4. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2016 – 2020

        9.4.1. Long Acting Oxycodone

        9.4.2. Short Acting Oxycodone

    9.5. Market Size (US$ Mn) Forecast By Product Type, 2021 – 2031

    9.6. Historical Market Size (US$ Mn) Trend Analysis By Application, 2016 – 2020

        9.6.1. Pain Management

        9.6.2. De-Addiction

    9.7. Market Size (US$ Mn) Forecast By Application, 2021 – 2031

    9.8. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2016 – 2020

        9.8.1. Retail Pharmacies

        9.8.2. Hospitals Pharmacies

    9.9. Market Size (US$ Mn) Forecast By Distribution Channel, 2021 – 2031

    9.10. Market Attractiveness Analysis

        9.10.1. By Country

        9.10.2. By Product Type

        9.10.3. By Application

        9.10.4. By Distribution Channel

    9.11. Key Mergers & Acquisitions

10. Asia Pacific Oxycodone Market Analysis 2016 – 2020 and Forecast 2021 – 2031

    10.1. Introduction

    10.2. Historical Market Size (US$ Mn) Analysis By Country, 2016 – 2020

        10.2.1. Greater China

        10.2.2. India

        10.2.3. Japan

        10.2.4. ASEAN

        10.2.5. Australia

        10.2.6. Rest of APAC

    10.3. Market Size (US$ Mn) Forecast By Country, 2021 – 2031

    10.4. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2016 – 2020

        10.4.1. Long Acting Oxycodone

        10.4.2. Short Acting Oxycodone

    10.5. Market Size (US$ Mn) Forecast By Product Type, 2021 – 2031

    10.6. Historical Market Size (US$ Mn) Trend Analysis By Application, 2016 – 2020

        10.6.1. Pain Management

        10.6.2. De-Addiction

    10.7. Market Size (US$ Mn) Forecast By Application, 2021 – 2031

    10.8. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2016 – 2020

        10.8.1. Retail Pharmacies

        10.8.2. Hospitals Pharmacies

    10.9. Market Size (US$ Mn) Forecast By Distribution Channel, 2021 – 2031

    10.10. Market Attractiveness Analysis

        10.10.1. By Country

        10.10.2. By Product Type

        10.10.3. By Application

        10.10.4. By Distribution Channel

    10.11. Key Mergers & Acquisitions

11. Middle East and Africa Oxycodone Market Analysis 2016 – 2020 and Forecast 2021 – 2031

    11.1. Introduction

    11.2. Historical Market Size (US$ Mn) Analysis By Country, 2016 – 2020

        11.2.1. GCC Countries

        11.2.2. South Africa

        11.2.3. Rest of Middle East and Africa

    11.3. Market Size (US$ Mn) Forecast By Country, 2021 – 2031

    11.4. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2016 – 2020

        11.4.1. Long Acting Oxycodone

        11.4.2. Short Acting Oxycodone

    11.5. Market Size (US$ Mn) Forecast By Product Type, 2021 – 2031

    11.6. Historical Market Size (US$ Mn) Trend Analysis By Application, 2016 – 2020

        11.6.1. Pain Management

        11.6.2. De-Addiction

    11.7. Market Size (US$ Mn) Forecast By Application, 2021 – 2031

    11.8. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2016 – 2020

        11.8.1. Retail Pharmacies

        11.8.2. Hospitals Pharmacies

    11.9. Market Size (US$ Mn) Forecast By Distribution Channel, 2021 – 2031

    11.10. Market Attractiveness Analysis

        11.10.1. By Country

        11.10.2. By Product Type

        11.10.3. By Application

        11.10.4. By Distribution Channel

    11.11. Key Mergers & Acquisitions

12. Forecast Factors: Relevance and Impact

13. Competition Analysis

    13.1. Competition Dashboard

    13.2. Company Deep Dive

        13.2.1. Purdue Pharma LP

            13.2.1.1. Overview

            13.2.1.2. Product and Application Portfolio

            13.2.1.3. Production Footprint

            13.2.1.4. Sales Footprint

            13.2.1.5. Channel Footprint

            13.2.1.6. Strategy

                13.2.1.6.1. Marketing Strategy

                13.2.1.6.2. Product Strategy

                13.2.1.6.3. Channel Strategy

        13.2.2. Pfizer Inc.

            13.2.2.1. Overview

            13.2.2.2. Product and Application Portfolio

            13.2.2.3. Production Footprint

            13.2.2.4. Sales Footprint

            13.2.2.5. Channel Footprint

            13.2.2.6. Strategy

                13.2.2.6.1. Marketing Strategy

                13.2.2.6.2. Product Strategy

                13.2.2.6.3. Channel Strategy

        13.2.3. Janssen Pharmaceuticals, Inc.

            13.2.3.1. Overview

            13.2.3.2. Product and Application Portfolio

            13.2.3.3. Production Footprint

            13.2.3.4. Sales Footprint

            13.2.3.5. Channel Footprint

            13.2.3.6. Strategy

                13.2.3.6.1. Marketing Strategy

                13.2.3.6.2. Product Strategy

                13.2.3.6.3. Channel Strategy

        13.2.4. Teva Pharmaceuticals

            13.2.4.1. Overview

            13.2.4.2. Product and Application Portfolio

            13.2.4.3. Production Footprint

            13.2.4.4. Sales Footprint

            13.2.4.5. Channel Footprint

            13.2.4.6. Strategy

                13.2.4.6.1. Marketing Strategy

                13.2.4.6.2. Product Strategy

                13.2.4.6.3. Channel Strategy

        13.2.5. Endo International Plc

            13.2.5.1. Overview

            13.2.5.2. Product and Application Portfolio

            13.2.5.3. Production Footprint

            13.2.5.4. Sales Footprint

            13.2.5.5. Channel Footprint

            13.2.5.6. Strategy

                13.2.5.6.1. Marketing Strategy

                13.2.5.6.2. Product Strategy

                13.2.5.6.3. Channel Strategy

        13.2.6. West-Ward Pharmaceuticals (Hikma’s US subsidiary)

            13.2.6.1. Overview

            13.2.6.2. Product and Application Portfolio

            13.2.6.3. Production Footprint

            13.2.6.4. Sales Footprint

            13.2.6.5. Channel Footprint

            13.2.6.6. Strategy

                13.2.6.6.1. Marketing Strategy

                13.2.6.6.2. Product Strategy

                13.2.6.6.3. Channel Strategy

        13.2.7. Mallinckrodt Pharmaceuticals Plc

            13.2.7.1. Overview

            13.2.7.2. Product and Application Portfolio

            13.2.7.3. Production Footprint

            13.2.7.4. Sales Footprint

            13.2.7.5. Channel Footprint

            13.2.7.6. Strategy

                13.2.7.6.1. Marketing Strategy

                13.2.7.6.2. Product Strategy

                13.2.7.6.3. Channel Strategy

        13.2.8. Mylan N.V.

            13.2.8.1. Overview

            13.2.8.2. Product and Application Portfolio

            13.2.8.3. Production Footprint

            13.2.8.4. Sales Footprint

            13.2.8.5. Channel Footprint

            13.2.8.6. Strategy

                13.2.8.6.1. Marketing Strategy

                13.2.8.6.2. Product Strategy

                13.2.8.6.3. Channel Strategy

        13.2.9. Impax Laboratories, Inc.

            13.2.9.1. Overview

            13.2.9.2. Product and Application Portfolio

            13.2.9.3. Production Footprint

            13.2.9.4. Sales Footprint

            13.2.9.5. Channel Footprint

            13.2.9.6. Strategy

                13.2.9.6.1. Marketing Strategy

                13.2.9.6.2. Product Strategy

                13.2.9.6.3. Channel Strategy

        13.2.10. Indivior Plc.

            13.2.10.1. Overview

            13.2.10.2. Product and Application Portfolio

            13.2.10.3. Production Footprint

            13.2.10.4. Sales Footprint

            13.2.10.5. Channel Footprint

            13.2.10.6. Strategy

                13.2.10.6.1. Marketing Strategy

                13.2.10.6.2. Product Strategy

                13.2.10.6.3. Channel Strategy

14. Global Oxycodone Market Analysis 2016 – 2020 and Forecast 2021 – 2031 By Region

    14.1. Introduction / Key Findings

    14.2. Historical Market Size (US$ Mn) Analysis By Region

        14.2.1. North America

        14.2.2. Latin America

        14.2.3. Europe

        14.2.4. Asia Pacific

        14.2.5. Middle East & Africa

    14.3. Market Size (US$ Mn) Forecast By Region

    14.4. Market Attractiveness Analysis By Region

15. Global Oxycodone Market Analysis 2016 – 2020 and Forecast 2021 – 2031, By Product Type

    15.1. Introduction/Key Finding

    15.2. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2016 – 2020

        15.2.1. Long Acting Oxycodone

        15.2.2. Short Acting Oxycodone

    15.3. Market Size (US$ Mn) Forecast By Product Type, 2021 – 2031

    15.4. Market Attractiveness Analysis By Product Type

16. Global Oxycodone Market Analysis 2016 – 2020 and Forecast 2021 – 2031, By Application

    16.1. Introduction/Key Finding

    16.2. Historical Market Size (US$ Mn) Trend Analysis By Application, 2016 – 2020

        16.2.1. Pain Management

        16.2.2. De-Addiction

    16.3. Market Size (US$ Mn) Forecast By Application, 2021 – 2031

    16.4. Market Attractiveness Analysis By Application

17. Global Oxycodone Market Analysis 2016 – 2020 and Forecast 2021 – 2031, By Distribution Channel

    17.1. Introduction/Key Finding

    17.2. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2016 – 2020

        17.2.1. Retail Pharmacies

        17.2.2. Hospitals Pharmacies

    17.3. Market Size (US$ Mn) Forecast By Distribution Channel, 2021 – 2031

    17.4. Market Attractiveness Analysis By Distribution Channel

18. Global Oxycodone Market Analysis 2016 – 2020 and Forecast 2021 – 2031

    18.1. Market Value Share Analysis By All Segment

    18.2. Y-o-Y Growth Analysis By All Segment

    18.3. Absolute $ Opportunity

19. Assumptions and Acronyms Used

20. Research Methodolog

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 01: Expenditure on Health, (% of GDP), by Country, 2021 – 2031

Table 02: Expenditure on Health, (% of GDP), by Country, 2021 – 2031

Table 03: North America Oxycodone Market size (US$ Mn) Analysis 2016 – 2020 and Forecast 2021 – 2031, By Country

Table 04: North America Oxycodone Market size (US$ Mn) Analysis 2016 – 2020 and Forecast 2021 – 2031, By Product Type

Table 05: North America Oxycodone Market size (US$ Mn) Analysis 2016 – 2020 and Forecast 2021 – 2031, By Application

Table 06: North America Oxycodone Market size (US$ Mn) Analysis 2016 – 2020 and Forecast 2021 – 2031, By Distribution Channel

Table 07: Latin America Oxycodone Market size (US$ Mn) Analysis 2016 – 2020 and Forecast 2021 – 2031, By Country

Table 08: Latin America Oxycodone Market size (US$ Mn) Analysis 2016 – 2020 and Forecast 2021 – 2031, By Product Type

Table 09: Latin America Oxycodone Market size (US$ Mn) Analysis 2016 – 2020 and Forecast 2021 – 2031, By Application

Table 10: Latin America Oxycodone Market size (US$ Mn) Analysis 2016 – 2020 and Forecast 2021 – 2031, By Distribution Channel

Table 11: Europe Oxycodone Market size (US$ Mn) Analysis 2016 – 2020 and Forecast 2021 – 2031, By Country

Table 12: Europe Oxycodone Market size (US$ Mn) Analysis 2016 – 2020 and Forecast 2021 – 2031, By Product Type

Table 13: Europe Oxycodone Market size (US$ Mn) Analysis 2016 – 2020 and Forecast 2021 – 2031, By Application

Table 14: Europe Oxycodone Market size (US$ Mn) Analysis 2016 – 2020 and Forecast 2021 – 2031, By Distribution Channel

Table 15: Asia Pacific Oxycodone Market size (US$ Mn) Analysis 2016 – 2020 and Forecast 2021 – 2031, By Country

Table 16: Asia Pacific Oxycodone Market size (US$ Mn) Analysis 2016 – 2020 and Forecast 2021 – 2031, By Product Type

Table 17: Asia Pacific Oxycodone Market size (US$ Mn) Analysis 2016 – 2020 and Forecast 2021 – 2031, By Application

Table 18: Asia Pacific Oxycodone Market size (US$ Mn) Analysis 2016 – 2020 and Forecast 2021 – 2031, By Distribution Channel

Table 19: MEA Oxycodone Market size (US$ Mn) Analysis 2016 – 2020 and Forecast 2021 – 2031, By Country

Table 20: MEA Oxycodone Market size (US$ Mn) Analysis 2016 – 2020 and Forecast 2021 – 2031, By Product Type

Table 21: MEA Oxycodone Market size (US$ Mn) Analysis 2016 – 2020 and Forecast 2021 – 2031, By Application

Table 22: MEA Oxycodone Market size (US$ Mn) Analysis 2016 – 2020 and Forecast 2021 – 2031, By Distribution Channel

Table 23: Global Oxycodone Market Size (US$ Mn) Analysis 2016 – 2020 and Forecast 2021 – 2031, By Region

Table 24: Global Oxycodone Market Size (US$ Mn) Analysis 2016 – 2020 and Forecast 2021 – 2031, By Product Type

Table 25: Global Oxycodone Market Size (US$ Mn) Analysis 2016 – 2020 and Forecast 2021 – 2031, By Application

Table 26: Global Oxycodone Market Size (US$ Mn) Analysis 2016 – 2020 and Forecast 2021 – 2031, By Distribution Channel   

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 01: Oxycodone Market Value Share By Region (2021)

Figure 02: Global Healthcare Expenditure in US$ Tn (2021 – 2031)

Figure 03: North America Synthetic & Semi synthetic Opioids Per Capita Consumption (mg)

Figure 04: Top 10 US States with Highest Opioid Prescription

Figure 05: Sources of Opioid Painkillers in North America

Figure 06: North America Oxycodone Market Value Share (2021A), By Country

Figure 07: North America Oxycodone Market Value Share (2021A), By Product Type, Application and Distribution Channel

Figure 08: North America Oxycodone Market Size (US$ Mn) Analysis, 2016 – 2020

Figure 09: North America Oxycodone Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2021 – 2031

Figure 10: North America Oxycodone Market Y-o-Y growth (%) Comparison, By Country, 2021 – 2031

Figure 11: U.S. Oxycodone Market size (US$ Mn) Analysis, 2016 – 2020

Figure 12: U.S. Oxycodone Market Value (US$ Mn) & Y-o-Y Growth (%), 2021 – 2031

Figure 13: Canada Oxycodone Market size (US$ Mn) Analysis, 2016 – 2020

Figure 14: Canada Oxycodone Market Value (US$ Mn) & Y-o-Y Growth (%), 2021 – 2031

Figure 15: North America Oxycodone Market Attractiveness Analysis, By Product Type

Figure 16: North America Oxycodone Market Attractiveness Analysis, Application

Figure 17: North America Oxycodone Market Attractiveness Analysis, By Distribution Channel

Figure 18: North America Oxycodone Market Attractiveness Analysis, By Country

Figure 19: Latin America Oxycodone Market Value Share (2021A), By Country

Figure 20: Latin America Oxycodone Market Value Share (2021A), By Product Type, Application and Distribution Channel

Figure 21: Latin America Oxycodone Market Size (US$ Mn) Analysis, 2016 – 2020

Figure 22: Latin America Oxycodone Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2021 – 2031

Figure 23: Latin America Oxycodone Market Y-o-Y growth (%) Comparison, By Country, 2021 – 2031

Figure 24: Brazil Oxycodone Market size (US$ Mn) Analysis, 2016 – 2020

Figure 25: Brazil Oxycodone Market Value (US$ Mn) & Y-o-Y Growth (%), 2021 – 2031

Figure 26: Mexico Oxycodone Market size (US$ Mn) Analysis, 2016 – 2020

Figure 27: Mexico Oxycodone Market Value (US$ Mn) & Y-o-Y Growth (%), 2021 – 2031

Figure 28: Latin America Oxycodone Market size (US$ Mn) Analysis, 2016 – 2020

Figure 29: Latin America Oxycodone Market Value (US$ Mn) & Y-o-Y Growth (%), 2021 – 2031

Figure 30: Latin America Oxycodone Market Attractiveness Analysis, By Product Type

Figure 31: Latin America Oxycodone Market Attractiveness Analysis, Application

Figure 32: Latin America Oxycodone Market Attractiveness Analysis, By Distribution Channel

Figure 33: Latin America Oxycodone Market Attractiveness Analysis, By Country

Figure 34: Europe Oxycodone Market Value Share (2021A), By Country

Figure 35: Europe Oxycodone Market Value Share (2021A), By Product Type, Application and Distribution Channel

Figure 36: Europe Oxycodone Market Size (US$ Mn) Analysis, 2016 – 2020

Figure 37: Europe Oxycodone Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2021 – 2031

Figure 38: Europe Oxycodone Market Y-o-Y growth (%) Comparison, By Country, 2021 – 2031

Figure 39: EU-4 Oxycodone Market size (US$ Mn) Analysis, 2016 – 2020

Figure 40: EU-4 Oxycodone Market Value (US$ Mn) & Y-o-Y Growth (%), 2021 – 2031

Figure 41: U.K. Oxycodone Market size (US$ Mn) Analysis, 2016 – 2020

Figure 42: U.K. Oxycodone Market Value (US$ Mn) & Y-o-Y Growth (%), 2021 – 2031

Figure 43: Russia Oxycodone Market size (US$ Mn) Analysis, 2016 – 2020

Figure 44: Russia Oxycodone Market Value (US$ Mn) & Y-o-Y Growth (%), 2021 – 2031

Figure 45: Rest of Europe Oxycodone Market size (US$ Mn) Analysis, 2016 – 2020

Figure 46: Rest of Europe Oxycodone Market Value (US$ Mn) & Y-o-Y Growth (%), 2021 – 2031

Figure 47: Europe Oxycodone Market Attractiveness Analysis, By Product Type

Figure 48: Europe Oxycodone Market Attractiveness Analysis, Application

Figure 49: Europe Oxycodone Market Attractiveness Analysis, By Distribution Channel

Figure 50: Europe Oxycodone Market Attractiveness Analysis, By Country

Figure 51: Asia Pacific Oxycodone Market Value Share (2021A), By Country

Figure 52: Asia Pacific Oxycodone Market Value Share (2021A), By Product Type, Application and Distribution Channel

Figure 53: Asia Pacific Oxycodone Market Size (US$ Mn) Analysis, 2016 – 2020

Figure 54: Asia Pacific Oxycodone Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2021 – 2031

Figure 55: Asia Pacific Oxycodone Market Y-o-Y growth (%) Comparison, By Country, 2021 – 2031

Figure 56: Greater China Oxycodone Market size (US$ Mn) Analysis, 2016 – 2020

Figure 57: Greater China Oxycodone Market Value (US$ Mn) & Y-o-Y Growth (%), 2021 – 2031

Figure 58: India Oxycodone Market size (US$ Mn) Analysis, 2016 – 2020

Figure 59: India Oxycodone Market Value (US$ Mn) & Y-o-Y Growth (%), 2021 – 2031

Figure 60: Japan Oxycodone Market size (US$ Mn) Analysis, 2016 – 2020

Figure 61: Japan Oxycodone Market Value (US$ Mn) & Y-o-Y Growth (%), 2021 – 2031

Figure 62: ASEAN Oxycodone Market size (US$ Mn) Analysis, 2016 – 2020

Figure 63: ASEAN Oxycodone Market Value (US$ Mn) & Y-o-Y Growth (%), 2021 – 2031

Figure 64: Australia Oxycodone Market size (US$ Mn) Analysis, 2016 – 2020

Figure 65: Australia Oxycodone Market Value (US$ Mn) & Y-o-Y Growth (%), 2021 – 2031

Figure 66: Rest of APAC Oxycodone Market size (US$ Mn) Analysis, 2016 – 2020

Figure 67: Rest of APAC Oxycodone Market Value (US$ Mn) & Y-o-Y Growth (%), 2021 – 2031

Figure 68: Asia Pacific Oxycodone Market Attractiveness Analysis, By Product Type

Figure 69: Asia Pacific Oxycodone Market Attractiveness Analysis, Application

Figure 70: Asia Pacific Oxycodone Market Attractiveness Analysis, By Distribution Channel

Figure 71: Asia Pacific Oxycodone Market Attractiveness Analysis, By Country

Figure 72: MEA Oxycodone Market Value Share (2021A), By Country

Figure 73: MEA Oxycodone Market Value Share (2021A), By Product Type, Application and Distribution Channel

Figure 74: MEA Oxycodone Market Size (US$ Mn) Analysis, 2016 – 2020

Figure 75: MEA Oxycodone Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2021 – 2031

Figure 76: MEA Oxycodone Market Y-o-Y growth (%) Comparison, By Country, 2021 – 2031

Figure 77: GCC Countries Oxycodone Market size (US$ Mn) Analysis, 2016 – 2020

Figure 78: GCC Countries Oxycodone Market Value (US$ Mn) & Y-o-Y Growth (%), 2021 – 2031

Figure 79: South Africa Oxycodone Market size (US$ Mn) Analysis, 2016 – 2020

Figure 80: South Africa Oxycodone Market Value (US$ Mn) & Y-o-Y Growth (%), 2021 – 2031

Figure 81: Rest of MEA Oxycodone Market size (US$ Mn) Analysis, 2016 – 2020

Figure 82: Rest of MEA Oxycodone Market Value (US$ Mn) & Y-o-Y Growth (%), 2021 – 2031

Figure 83: MEA Oxycodone Market Attractiveness Analysis, By Product Type

Figure 84: MEA Oxycodone Market Attractiveness Analysis, Application

Figure 85: MEA Oxycodone Market Attractiveness Analysis, By Distribution Channel

Figure 86: MEA Oxycodone Market Attractiveness Analysis, By Country

Figure 87: Global Oxycodone Market Attractiveness Analysis, By Region

Figure 88: Global Oxycodone Market Value Share Analysis, By Region, 2021 & 2031

Figure 89: Global Oxycodone Market Attractiveness Analysis, By Product Type

Figure 90: Global Oxycodone Market Value Share Analysis, By Product Type, 2021 & 2031

Figure 91: Global Oxycodone Market Attractiveness Analysis, By Application

Figure 92: Global Oxycodone Market Value Share Analysis, By Application, 2021 & 2031

Figure 93: Global Oxycodone Market Attractiveness Analysis, By Distribution Channel

Figure 94: Global Oxycodone Market Value Share Analysis, By Distribution Channel, 2021 & 2031

Figure 95: Global Oxycodone Market Size and Y-o-Y, 2013 - 2017

Figure 96: Global Oxycodone Market Size (US$ Mn) & Y-o-Y Growth (%), 2021 – 2031

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports
Google translate